trending Market Intelligence /marketintelligence/en/news-insights/trending/1XMzNqzejRXi7DHjAic5Jg2 content esgSubNav
In This List

Johnson & Johnson, Actelion deal back on the table

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Johnson & Johnson, Actelion deal back on the table

Johnson & Johnson has re-entered negotiations with Actelion Ltd. for a possible transaction.

The company made a takeover offer for Actelion in November but ended discussions for a possible deal earlier in December as it was not able to reach an agreement that would create adequate value for its shareholders.

Johnson & Johnson said there is no guarantee the renewed talks will lead to a transaction. It also does not intend to make additional comments until it is appropriate to do so, or a formal agreement is reached.

French drugmaker Sanofi is also in advanced talks to acquire the Swiss drugmaker.